• Biohaven Pharmaceuticals

Helping to Research Potential Migraine Treatments

Clinical Trials are a great way to help contribute to our understanding of pediatric migraines and research potential treatments. Listen to Tresor and Sophia's story of migraine and their experience participating in a clinical trial.

Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 6 and 17 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.

Recent Posts

See All